At UCB, everything we do starts with a simple question: “How will this create value for people living with severe diseases?” To do this, our approach to innovation keeps patients at the center. We use patient insights to inform our science to build solutions to deliver to patients. Innovation is ongoing as we continue to find solutions to meet the unmet needs of patients. We are committed to continuing to innovate – from patient to science to solution. We are inspired by patients and driven by science to deliver what patients value.
Digital Business Transformation
Together, we can amplify the power of scientific innovation through digital transformation to create sustainable value, ensuring that patients can live the lives they choose, now and in the future.
To support a model of open innovation, UCB is engaged in partnerships and efforts to foster value for patients. For example, to foster and accelerate clinical trials, UCB partners with TransCelerate Biopharma Inc. to engage with industry organizations, patients, and global regulatory authorities on best approaches for adapting research models to include patient-driven solutions and data.
We are also collaborating with the American Gastroenterological Association to address the lack of easily accessible and accurate information about inflammatory bowel disease for patients of childbearing age.